Hackensack Meridian Health Takes on Cancer Care with New Tech Partnership | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Hackensack Meridian Health Takes on Cancer Care with New Tech Partnership

June 5, 2017
by Rajiv Leventhal
| Reprints

New Jersey-based Hackensack Meridian Health is collaborating with IBM Watson and health data company Cota with the end goal of helping oncologists make evidence- and outcomes-based clinical decisions for their cancer patients.

Officials said in an announcement that the idea is to bring Cota's value-based care and real-world data into IBM's Watson for Oncology clinical decision support tool, which Hackensack Meridian Health oncologists will then use in a pilot to help inform patient care.

The Hackensack Meridian Health pilot will be rolled out to an initial group of 10 oncologists and will be available to as many as 500 patients now through the end of October. Watson for Oncology will be used by oncologists to help identify and rank treatment options, providing links to supporting evidence, empowering oncologists with unparalleled insights as they consider the right course for their patient, officials noted.

What’s more, the New York City-based Cota will derive abstracted and benchmark data and embed patient classification into Watson for Oncology to analyze meaning and context from clinical notes, reports and key patient information within the context of treatment planning. In the second phase of the pilot, evidence-based treatment recommendations and care paths in Watson will include insights on bundled payment assignments, officials stated.

The combined use of Watson for Oncology and Cota real-world evidence aims to present treatment recommendations alongside insights on real-world outcomes to the oncologist at the point of care. Cota provides real-world evidence along with cancer cohort analytics incorporating efficacy, toxicity, and cost data, via the Cota Nodal Address (CNA), a patented real-world data classification system that groups patients into clinically meaningful cohorts. And, IBM's Watson for Oncology provides oncologists with personalized, evidence-based decision support, combining attributes from a patient's electronic medical record (EMR) with clinical guidelines, medical literature and expertise from training with Memorial Sloan Kettering.

“Hackensack Meridian Health is excited to expand our existing partnership with Cota by incorporating the deep insights Watson for Oncology has to offer," Robert Garrett, co-CEO of Hackensack Meridian Health, said in a statement. "We pride ourselves on our ability to provide patients with cutting edge care and this pilot will help us achieve that mission while also reducing the total cost of care and getting us closer to value-based care trends, like bundled payments. Our collaboration with IBM and Cota will allow us to do just that, while furthering our commitment to innovation and stretching the limits of healthcare."

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Study will Leverage Connecticut HIE to Help Prevent Suicides

A new study will aim to leverage CTHealthLink, a physician-led health information exchange (HIE) in Connecticut, to help identify the factors leading to suicide and to ultimately help prevent those deaths.

Duke Health First to Achieve HIMSS Stage 7 Rating in Analytics

North Carolina-based Duke Health has become the first U.S. healthcare institution to be awarded the highest honor for analytic capabilities by HIMSS Analytics.

NIH Releases First Dataset from Adolescent Brain Development Study

The National Institutes of Health (NIH) announced the release of the first dataset from the Adolescent Brain Cognitive Development (ABCD) study, which will enable scientists to conduct research on the many factors that influence brain, cognitive, social, and emotional development.

Boston Children's Accelerates Data-Driven Approach to Clinical Research

In an effort to bring a more data-driven approach to clinical research, Boston Children’s Hospital has joined the TriNetX global health research network.

Paper Records, Films Most Common Type of Healthcare Data Breach, Study Finds

Despite the high level of hospital adoption of electronic health records and federal incentives to do so, paper and films were the most frequent location of breached data in hospitals, according to a recent study.

AHA Appoints Senior Advisor for Cybersecurity and Risk

The American Hospital Association (AHA) has announced that John Riggi has joined the association as senior advisor for cybersecurity and risk.